Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
aggression
agitation
angiography, cerebral
autonomic dysfunction
bath salts, psychoactive
behavior, combative
behavioral disorder
behavioral disorder, acute
cannabinoids
cannabinoids, synthetic
CAT scan, abnormal
cerebrovascular accident
Clinical Pathologic Conference(C.P.C.)
cluster, geographic
complications
confusion
creatinine, elevated
delirium
delusion
designer drugs
drowsiness
drug abuse
drug abuse, toxic screen In
drug induced neurologic disorders
drug overdose
efficacy
encephalopathy
euphoria
hallucination
hallucinogens
intracerebral hemorrhage
lactic acidemia
marihuana
mental status, abnormal
methcathinone
mortality
nabilone
neurologic complications
neurotoxin
paranoia
Parkinson disease
Parkinson disease, nonmotor problems of
Parkinson disease, treatment of
psychosis
renal failure
renal failure, acute
rhabdomyolysis
safety
seizure
self harm
spice
stimulant drugs
stuporous
subarachnoid hemorrhage
sympathomimetic drugs
toxic encephalopathy
treatment of neurologic disorder
urine test in toxic screen
vasospasm
vasospasm, cerebral
violent behavior
zombie
Showing articles 1900 to 1950 of 6776 << Previous Next >>

Antithrombotic Management of Patients with Prosthetic Heart Valves: Current Evidence and Future Trends
Lancet 374:565-576, Sun,J.C.J.,et al, 2009

Who Is Ineligible for Warfarin in Atrial Fibrillation?
Lancet 374:510-511, Verheugt,F.W.A., 2009

Anti-N-Methyl-D-Aspartate Receptor (NHMDAR) Encephalitis in Children and Adolescents
Ann Neurol 66:11-18,1, Florance,N.R.,et al, 2009

Lamotrigine Kinetics Within the Menstrual Cycle, After Menopause, and with Oral Contraceptives
Neurol 73:1388-1393, Wegner,I.,et al, 2009

Point-of-Care International Normalized Ratio Testing Accelerates Thrombolysis in Patients With Acute Ischemic Stroke Using Oral Anticoagulants
Stroke 40:3547-3551, Rizos,T.,et al, 2009

Chitosan May Decrease Serum Valproate and Increase Risk of Seizure Reappearance
BMJ 339:a2163, Striano,P.,et al, 2009

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 66:403-406, 261, 262, Schweikert,A.,et al, 2009

Natalizumab and Central Nervous System Lymphoma: No Clear Association
Ann Neurol 66:261-262, Bozic,C.,et al, 2009

Natalizumab: A Double-Edged Sword?
Ann Neurol 66:262-263, DeAngelis,L., 2009

Seizure Relapse and Development of Drug Resistance Following Long-Term Seizure Remission
Arch Neurol 66:1233-1239, Schiller,Y., 2009

The Clinical Course of Advanced Dementia
NEJM 361:1529-1538, 1595, Mitchell,S.,et al, 2009

Medial Medullary Infarction: Clinical, Imaging, and Outcome Study in 86 Consecutive Patients
Stroke 40:3221-3225, Kim,J. &Han,Y., 2009

Diagnosis and Management of Neuropathic Pain
BMJ 339:391-395, Freynhagen,R. &Bennett,M.I., 2009

Neurologic Immune Reconstitution Inflammatory Syndrome in HIV/AIDS: Outcome and Epidemiology
Neurol 72:835-841, McCombe,J.A.,et al, 2009

Cerebral Microbleed Preceding Symptomatic Intracerebral Hemorrhage in a Stroke-Free Person
Neurol 72:763-765, Vernooij,M.W.,et al, 2009

Thrombolytic Therapy for Patients Who Wake-Up With Stroke
Stroke 40:827-832, Barreto,A.D.,et al, 2009

A Multicenter, Prospective Pilot Study of Gamma Knife Radiosurgery for Mesial Temporal Lobe Epilepsy: Seizure Response, Adverse Events, and Verbal Memory
Ann Neurol 65:167-175, Barbaro,N.M.,et al, 2009

Posterior Reversible Encephalopathy Syndrome After Intravenous Caffeine for Post-Lumbar Puncture Headaches
AJNR 30:586-587, Ortiz,G.A.,et al, 2009

Hepatitis B Vaccine and the Risk of CNS Inflammatory Demyelination in Childhood
Neurol 72:873-880,870, Mikaeloff,Y.,et al, 2009

Intravascular Lymphoma Masquerading as Multiembolic Stroke Developing After Coronary Artery By-Pass Surgery
The Neurologist 15:98-101, Sumer,M.,et al, 2009

Sustained-Release Oral Fampridine in Multiple Sclerosis: A Randomised, Double-Blind, Controlled Trial
Lancet 373:732-738, Goodman,A.D.,et al, 2009

Unexplained Seizures in an Infant
Lancet 373:94, Astuto,M.,et al, 2009

Carbon Monoxide Poisoning
NEJM 360:1217-1225, Weaver,L.K., 2009

Moyamoya Disease and Moyamoya Syndrome
NEJM 360:1226-1237, Scott,R.M. &Smith,E.R., 2009

Multiple Sclerosis Therapeutics: Unexpected Outcomes Clouding Undisputed Successes
Neurol 72:1008-1015, Wiendl,H. &Hohlfeld,R., 2009

Effect of Age on Stroke Prevention Therapy in Patients with Atrial Fibrillation: The Atrial Fibrillation Investigators
Stroke 40:1410-1416, van Walraven,C.,et al, 2009

Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
NEJM 360:2066-2078,2127, The ACTIVE Investigators, 2009

Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009

PML-IRIS in Patients with HIV Infection: Clinical Manifestations and Treatment with Steroids
Neurol 72:1458-1464,1454, Tan,K.,et al, 2009

Does the Combination of Warfarin and Aspirin Have a Place in Secondary Stroke Prevention? No
Stroke 40:1944-1945,1946, Fisher,M., 2009

Does the Combination of Warfarin and Aspirin Have a Place in Secondary Stroke Prevention? Yes
Stroke 40:1942-1943,1946, Furlan,A.J., 2009

Overweight After Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson Disease: Long Term Follow-Up
JNNP 80:484-488, Bannier,S.,et al, 2009

High Doses of Deferiprone May Be Associated with Cerebellar Syndrome
BMJ 338:653, Beau-Salinas,F.,et al, 2009

Fast-In, Fast-Out
Lancet 373:1398, Hefele,B.,et al, 2009

Prior Antiplatelet Use Dose Not Affect Hemorrhage Growth or Outcome After ICH
Neurol 72:1397-1402,1376, Sansing,L.H.,et al, 2009

Cognitive Function at 3 Years of Age After Fetal Exposure to Antiepileptic Drugs
NEJM 360:1597-1605,1667, Meador,K.J.,et al, 2009

Deep Brain Stimulation for Primary Generalized Dystonia: Long-Term Outcomes
Arch Neurol 66:465-470, Isaias,I.U.,et al, 2009

Recurrent Pericarditis Due to Natalizumab Treatment
Neurol 72:1616-1617, Cohen,M.,et al, 2009

Memantine Induces Reversible Neurologic Impairment in Patients with MS
Neurol 72:1630-1633, Villoslada,P.,et al, 2009

A Systematic Review of Antiepilpetic Drug Initiation and Withdrawal
The Neurologist 15:122-131, Shih,J.J &Ochoa,J.G., 2009

Antivenom for Critically Ill Children with Neurotoxicity from Scorpion Stings
NEJM 360:2090-2098, Boyer,L.V.,et al, 2009

Long-Term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
Arch Neurol 66:563-570, Parkinson Sutdy Group CALM Cohort Investigators, 2009

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol 66:593-599, Boster,A.,et al, 2009

Fomepizole for Ethylene Glycol and Methanol Poisoning
NEJM 360:2216-2223, Brent,J., 2009

Long-Term Effects of the Concomitant Use of Memantine with Cholinesterase Inhibition in Alzheimer Disease
JNNP 80:600-607, Lopez,O.L.,et al, 2009

Intracerebral Haemorrhage
Lancet 373:1632-1644, Qureshi,A.I.,et al, 2009

Thrombolysis in Young Adults with Ischemic Stroke
Stroke 40:2085-2091, Putaala,J.,et al, 2009

Treatment of Atherosclerotic Intracranial Arterial Stenosis
Stroke 40:2257-2261, Turan,T.N.,et al, 2009

DNA �-Amyloid1-42 Trimer Immunization for Alzheimer Disease in a Wild-Type Mouse Model
JAMA 302:1796-1802, Lambracht-Washington,D.,et al, 2009

Intracranial Atherosclerotic Disease: An Update
Ann Neurol 66:730-738, Qureshi,A.,et al, 2009



Showing articles 1900 to 1950 of 6776 << Previous Next >>